IRADIMED (IRMD) Reports Q2 EPS of $0.13

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to IRADIMED (IRMD) Reports Q2 EPS of $0.13

Roth Capital Starts IRadimed Corp (IRMD) at Buy

August 11, 2014 7:52 AM EDT

Roth Capital initiated coverage on IRadimed Corp (NASDAQ: IRMD) with a Buy rating and a price target of $14.00.

For an analyst ratings summary and ratings history on IRadimed Corp click here. For more ratings news on IRadimed Corp click here.

Shares of IRadimed Corp closed at $11.03 yesterday.

... More